| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CGH.2014.12.014 |
| P698 | PubMed publication ID | 25528010 |
| P50 | author | Nezam Afdhal | Q60650815 |
| P2093 | author name string | David R Nelson | |
| Bruce R Bacon | |||
| Eric J Lawitz | |||
| Lee-Jen Wei | |||
| John G McHutchison | |||
| Keyur Patel | |||
| Imad Nasser | |||
| Stuart C Gordon | |||
| Jyotsna Garg | |||
| Tracy L Challies | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| hepatitis B | Q6853 | ||
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 772-9.e1-3 | |
| P577 | publication date | 2014-12-18 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study | |
| P478 | volume | 13 |
| Q90700183 | A New Multimodel Machine Learning Framework to Improve Hepatic Fibrosis Grading Using Ultrasound Elastography Systems from Different Vendors |
| Q90458205 | Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data |
| Q38970883 | Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa? |
| Q88881122 | Assessing the consistency of liver fibrosis results obtained through biopsy and transient elastography in patients suffering from chronic hepatitis C |
| Q38843387 | CROI 2016: Viral Hepatitis and Liver Fibrosis. |
| Q50041788 | Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study |
| Q37632907 | Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis |
| Q41010688 | Clinical Applications of the Eosinophilic Esophagitis Diagnostic Panel |
| Q42272368 | Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona |
| Q48234623 | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. |
| Q39354122 | Comparison of laboratory tests, ultrasound, or MRE to detect fibrosis in patients with non-alcoholic fatty liver disease: A meta-analysis |
| Q41456415 | Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography |
| Q62496196 | Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study |
| Q54247048 | Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels. |
| Q59793497 | Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences |
| Q40049943 | Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment |
| Q36047930 | Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease |
| Q40724577 | Editorial: A New Spin on Magnetic Resonance Elastography |
| Q59351829 | Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL |
| Q40261026 | Evaluation of splenic perfusion and spleen size using dynamic computed tomography: Usefulness in assessing degree of liver fibrosis. |
| Q57490314 | Expert opinion on the management of hepatitis C infection in Kuwait |
| Q35822068 | Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis |
| Q64242882 | Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening |
| Q43923983 | Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. |
| Q26771433 | Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical Approach |
| Q51161258 | Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. |
| Q94551711 | Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients |
| Q87339765 | Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use? |
| Q93046532 | Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography |
| Q30372276 | Low Pretreatment Acoustic Radiation Force Impulse Imaging (ARFI) Values Predict Sustained Virological Response in Antiviral Hepatitis C Virus (HCV) Therapy |
| Q26746929 | Natural regression of fibrosis in chronic hepatitis B |
| Q91264430 | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies |
| Q26744631 | Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? |
| Q38365125 | Noninvasive assessment of liver function. |
| Q30249400 | Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q52692830 | Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. |
| Q55010500 | Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. |
| Q50445732 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. |
| Q55276444 | Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection. |
| Q38655966 | Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. |
| Q40084913 | Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease |
| Q36880302 | The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease |
| Q28079445 | Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? |
| Q41711121 | Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C. |
| Q90621364 | Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis |
| Q60044365 | Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia |
| Q30358290 | Ultrasound Elastography: Review of Techniques and Clinical Applications. |
| Q91655515 | Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice |
| Q40345852 | Utilization of FibroScan Testing in Hepatitis C Virus Management |
| Q54229942 | Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. |
Search more.